Cargando…
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
INTRODUCTION: The Kingdom of Saudi Arabia was one of the first countries to implement a COVID-19 vaccination program. This study estimated the safety and reactogenicity of the ChAdOx1-S vaccine after the first dose administered to adults. METHODS: This cross-sectional study included 1592 randomly se...
Autores principales: | Al Bahrani, Salma, Albarrak, Ali, Alghamdi, Othman Ali, Alghamdi, Mesfer Abdullah, Hakami, Fatimah H., Al Abaadi, Asmaa K., Alkhrashi, Sausan A., Alghamdi, Mansour Y., Almershad, Meshael M., Alenazi, Mansour Moklif, El Gezery, Mohamed Hany, Jebakumar, Arulanantham Zechariah, Al-Tawfiq, Jaffar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310569/ https://www.ncbi.nlm.nih.gov/pubmed/34320413 http://dx.doi.org/10.1016/j.ijid.2021.07.052 |
Ejemplares similares
-
COVID-19 vaccine had a significant positive impact on patients with SARS-COV-2 during the third (Omicron) wave in Saudi Arabia
por: AlBahrani, Salma, et al.
Publicado: (2022) -
Initial viral cycle threshold values in patients with COVID-19 and their clinical significance
por: AlBahrani, Salma, et al.
Publicado: (2022) -
Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
por: AlBahrani, Salma, et al.
Publicado: (2023) -
Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients
por: AlBahrani, Salma, et al.
Publicado: (2021) -
Clinical Presentation and Outcome of Hospitalized Patients With COVID-19 in the First and Second Waves in Saudi Arabia
por: AlBahrani, Salma, et al.
Publicado: (2022)